LearningRx1 prostate cancer | http://www.learningrx.org

Dementia risk may be raised by hormone therapy for prostate cancer...

Dec 5, 2016 by

A study published in JAMA Oncology found that men with prostate cancer who had ADT (androgen deprivation therapy) were nearly twice as likely to be diagnosed with dementia in the five years after the ADT treatment, compared to men...

read more

prostate cancer therapy may raise Alzheimer’s risk

Dec 24, 2015 by

Androgen deprivation therapy (ADT) , which lowers testosterone, may increase the risk of developing Alzheimer’s for men receiving the treatment for prostate cancer....

read more